| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | China | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Hungary | 2 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Heterocyclic compounds | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ferdinandy Peter | 9 |
| #2 | Csont Tamas | 6 |
| #3 | Csonka Csaba | 5 |
| #4 | Varga Zoltan | 4 |
| #5 | Görbe Anikó | 4 |
| #6 | Csont Tamas Balint | 4 |
| #7 | Varga Zoltán | 3 |
| #8 | Kis-Tamas Attila | 2 |
| #9 | Takacs Ferenc Tamas | 2 |
| #10 | Goerbe Aniko | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP2584040A1 | Compounds for treatment of ischemic injury | |
| HU1000676D0 | Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved | |
| HU0500692D0 | Use of mmp inhibitors in the preparation of pharmaceutical compositions having cardioprotective activity |